Ulahannan, Susanna
Sarah Cannon · OU Health Stephenson Cancer Center
4 papers on CoChatORCID 0000-0002-7234-2283
Most cited papers
- Verified
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Llovet, J. M., Kudo, M., Merle, P., Meyer, T., Qin, S., Ikeda, M., Xu, R., Edeline, J., Ryoo, B.-Y., Ren, Z., et al. (2023) · The Lancet Oncology
Hepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and Studies
Cited by 469
- Verified
Divarasib plus cetuximab in KRAS G12C-positive colorectal cancer: a phase 1b trial
Desai, J., Alonso, G., Kim, S. H., Cervantes, A., Karasic, T., Medina, L., Shacham-Shmueli, E., Cosman, R., Falcon, A., Gort, E., et al. (2024) · Nature Medicine
Colorectal Cancer Treatments and StudiesLung Cancer Treatments and Mutations
Cited by 144
- Verified
A12 The SHP2 Inhibitor RMC-4630 in Patients with KRAS-Mutant Non-Small Cell Lung Cancer: Preliminary Evaluation of a First-in-Man Phase 1 Clinical Trial
Ou, S. I., Koczywas, M., Ulahannan, S., Janne, P., Pacheco, J., Burris, H., McCoach, C., Wang, J. S., Gordon, M., Haura, E., et al. (2020) · Journal of Thoracic Oncology
Protein Tyrosine PhosphatasesLung Cancer Treatments and Mutations
Cited by 73
- Verified
P-325 Oral delivery of a single microbial strain, EDP1503, induces anti-tumor responses via gut-mediated activation of both innate and adaptive immunity
McHale, D., Francisco-Anderson, L., Sandy, P., Shariffudin, S., Goldberg, M., Gardner, H., Abdou, M., Kashyap, S., Argueta, S., Parameswaran, P., et al. (2020) · Annals of Oncology
Probiotics and Fermented FoodsBacterial Cancer Therapy
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free